NIHON PHARMACEUTICAL CO., LTD.
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Subsidiary
- Established
- 1921-08-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.nihon-pharm.co.jp
Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.
Phase 3
Completed
- Conditions
- Chronic Inflammatory Demyelinating Polyneuropathy
- Interventions
- First Posted Date
- 2013-04-04
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 49
- Registration Number
- NCT01824251
- Locations
- π―π΅
Nihon Pharmaceutical Co., Ltd, Osaka, Japan
Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
Phase 3
Completed
- Conditions
- Stevens-Johnson SyndromeToxic Epidermal Necrolysis
- Interventions
- First Posted Date
- 2012-10-01
- Last Posted Date
- 2014-07-02
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 10
- Registration Number
- NCT01696500
- Locations
- π―π΅
Nihon Pharmaceutical Co., Ltd, Tokyo, Japan
Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy
Phase 3
Completed
- Conditions
- Gastric CancerColon Nos Polypectomy Tubular AdenomaGastric Adenoma
- Interventions
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2012-06-29
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 33
- Registration Number
- NCT01411189
- Locations
- π―π΅
Nihon Pharmaceutical Co., Ltd, Tokyo, Japan
Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2012-06-29
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 85
- Registration Number
- NCT01411176
- Locations
- π―π΅
Nihon Pharmaceutical Co., Ltd, Tokyo, Japan
Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids
- First Posted Date
- 2011-08-03
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 56
- Registration Number
- NCT01408550
Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2010-10-25
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 20
- Registration Number
- NCT00809822
Phase III General Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy
Phase 3
Completed
- Conditions
- Stomach Diseases
- Interventions
- Drug: NPO-11
- First Posted Date
- 2008-09-03
- Last Posted Date
- 2010-11-09
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 100
- Registration Number
- NCT00745459
Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy
Phase 3
Completed
- Conditions
- Patients Undergoing Gastric Endoscopy
- Interventions
- Drug: NPO-11Drug: Placebo
- First Posted Date
- 2008-08-27
- Last Posted Date
- 2010-11-09
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 80
- Registration Number
- NCT00742599
Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men
Phase 3
Completed
- Conditions
- Healthy
- Interventions
- Drug: NPO-11
- First Posted Date
- 2008-08-22
- Last Posted Date
- 2010-11-09
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT00740324
Β© Copyright 2025. All Rights Reserved by MedPath